Obesity and cardiovascular disease.
作者信息
Apovian Caroline M, Gokce Noyan
机构信息
Boston Medical Center, Boston, MA 02118, USA.
出版信息
Circulation. 2012 Mar 6;125(9):1178-82. doi: 10.1161/CIRCULATIONAHA.111.022541.
Abstract
摘要
相似文献
1
Obesity and cardiovascular disease.肥胖与心血管疾病。
Circulation. 2012 Mar 6;125(9):1178-82. doi: 10.1161/CIRCULATIONAHA.111.022541.
2
Letter by hendricks regarding article, "obesity and cardiovascular disease".亨德里克斯就“肥胖与心血管疾病”一文所写的信。
Circulation. 2012 Sep 18;126(12):e191; author reply e192. doi: 10.1161/CIRCULATIONAHA.112.115444.
3
Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study.为期两年的肥胖和超重成年人用控释苯丁胺/托吡酯持续减肥和代谢获益（SEQUEL）：一项随机、安慰剂对照、3 期扩展研究。
Am J Clin Nutr. 2012 Feb;95(2):297-308. doi: 10.3945/ajcn.111.024927. Epub 2011 Dec 7.
4
European Society of Hypertension Working Group on Obesity: obesity drugs and cardiovascular outcomes.欧洲高血压学会肥胖问题工作组：肥胖药物与心血管结局
J Hypertens. 2011 Feb;29(2):189-93. doi: 10.1097/HJH.0b013e3283427c8b.
5
Drug treatment of obesity.
JAMA Intern Med. 2014 Aug;174(8):1414-5. doi: 10.1001/jamainternmed.2014.1646.
6
Drug treatment of obesity.
JAMA Intern Med. 2014 Aug;174(8):1414. doi: 10.1001/jamainternmed.2014.1640.
7
Drug treatment of obesity--reply.
JAMA Intern Med. 2014 Aug;174(8):1415-6. doi: 10.1001/jamainternmed.2014.1635.
8
Phentermine and topiramate extended-release for the obesity: new kids on the block.用于治疗肥胖症的缓释苯丁胺和托吡酯：新出现的药物。
Recent Pat Cardiovasc Drug Discov. 2013 Apr;8(1):35-41. doi: 10.2174/15748901112079990012.
9
Weight-loss therapy in type 2 diabetes: effects of phentermine and topiramate extended release.2 型糖尿病的减肥治疗：苯丁胺和托吡酯缓释的效果。
Diabetes Care. 2014 Dec;37(12):3309-16. doi: 10.2337/dc14-0930. Epub 2014 Sep 23.
10
The success of bariatric surgery as treatment of type 2 diabetes should be a call to revitalize anti-obesity drug discovery and development.减肥手术作为2型糖尿病的治疗方法取得成功，应该促使人们重振抗肥胖药物的研发。
Curr Opin Investig Drugs. 2008 Apr;9(4):355-6.
引用本文的文献
1
Safety and Effectiveness of Tirzepatide Use in Obesity Without Type 2 Diabetes Mellitus.替尔泊肽用于非2型糖尿病肥胖症的安全性和有效性
Cureus. 2024 Jan 7;16(1):e51788. doi: 10.7759/cureus.51788. eCollection 2024 Jan.
2
The predictive role of laboratory parameters in cardiovascular risk assessment in obese.实验室参数在肥胖人群心血管风险评估中的预测作用。
Medicine (Baltimore). 2023 Aug 4;102(31):e34634. doi: 10.1097/MD.0000000000034634.
3
Phenotypic and functional features of B cells from two different human subcutaneous adipose depots.来自人体两个不同皮下脂肪组织的 B 细胞的表型和功能特征。
PLoS One. 2023 Apr 27;18(4):e0285025. doi: 10.1371/journal.pone.0285025. eCollection 2023.
4
Mental stress induces endothelial dysfunction by AT1R-mediated redox imbalance in overweight/obese men.精神压力通过超重/肥胖男性 AT1R 介导的氧化还原失衡诱导内皮功能障碍。
Braz J Med Biol Res. 2023 Mar 24;56:e12547. doi: 10.1590/1414-431X2023e12547. eCollection 2023.
5
Association of Bariatric Surgery With Cardiovascular Outcomes in Adults With Severe Obesity and Nonalcoholic Fatty Liver Disease.肥胖症合并非酒精性脂肪性肝病成人行减重手术与心血管结局的相关性。
JAMA Netw Open. 2022 Oct 3;5(10):e2235003. doi: 10.1001/jamanetworkopen.2022.35003.
6
Low Cardiorespiratory Fitness, Muscular Fitness, and Flexibility Are Associated with Body Fat Distribution and Obesity Risk Using Bioelectrical Impedance in Taiwanese Adults.在台湾成年人中，使用生物电阻抗法，低心肺功能适应性、肌肉适应性和柔韧性与体脂分布和肥胖风险有关。
Int J Environ Res Public Health. 2022 Jul 21;19(14):8858. doi: 10.3390/ijerph19148858.
7
Obesity Accelerates Age-Associated Defects in Human B Cells Through a Metabolic Reprogramming Induced by the Fatty Acid Palmitate.肥胖通过棕榈酸诱导的代谢重编程加速人类B细胞中与年龄相关的缺陷。
Front Aging. 2022 Jan 13;2:828697. doi: 10.3389/fragi.2021.828697. eCollection 2021.
8
Docosahexaenoic acid enhances hippocampal insulin sensitivity to promote cognitive function of aged rats on a high-fat diet.二十二碳六烯酸增强海马胰岛素敏感性，促进高脂饮食老龄大鼠认知功能。
J Adv Res. 2023 Mar;45:31-42. doi: 10.1016/j.jare.2022.04.015. Epub 2022 Apr 30.
9
Phentermine-Associated Atrial Fibrillation: A Case Report and Literature Review.芬特明相关性心房颤动：一例病例报告及文献综述
Eur J Case Rep Intern Med. 2022 Mar 28;9(3):003267. doi: 10.12890/2022_003267. eCollection 2022.
10
Revitalizing the ethanologenic bacterium for sugar reduction in high-sugar-content fruits and commercial products.重振产乙醇细菌以降低高糖水果和商业产品中的糖分。
Bioresour Bioprocess. 2021;8(1):119. doi: 10.1186/s40643-021-00467-2. Epub 2021 Dec 2.
本文引用的文献
1
New drug targets for the treatment of obesity.治疗肥胖的新药物靶点。
Clin Pharmacol Ther. 2011 Jul;90(1):40-51. doi: 10.1038/clpt.2011.82. Epub 2011 Jun 8.
2
Bariatric surgery and cardiovascular risk factors: a scientific statement from the American Heart Association.减肥手术与心血管危险因素：美国心脏协会的科学声明
Circulation. 2011 Apr 19;123(15):1683-701. doi: 10.1161/CIR.0b013e3182149099. Epub 2011 Mar 14.
3
Favorable changes in cardiac geometry and function following gastric bypass surgery: 2-year follow-up in the Utah obesity study.胃旁路手术后心脏几何形状和功能的有利变化：犹他州肥胖研究的 2 年随访。
J Am Coll Cardiol. 2011 Feb 8;57(6):732-9. doi: 10.1016/j.jacc.2010.10.017.
4
Pharmacotherapies for obesity: past, current, and future therapies.肥胖症的药物治疗：过去、当前及未来的疗法
J Obes. 2011;2011:179674. doi: 10.1155/2011/179674. Epub 2010 Dec 12.
5
Body-mass index and mortality among 1.46 million white adults.146 万白人成年人的体重指数与死亡率。
N Engl J Med. 2010 Dec 2;363(23):2211-9. doi: 10.1056/NEJMoa1000367.
6
Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects.西布曲明对超重和肥胖受试者心血管结局的影响。
N Engl J Med. 2010 Sep 2;363(10):905-17. doi: 10.1056/NEJMoa1003114.
7
Abdominal subcutaneous and visceral adipose tissue and insulin resistance in the Framingham heart study.弗雷明汉心脏研究中心的腹部皮下和内脏脂肪组织与胰岛素抵抗。
Obesity (Silver Spring). 2010 Nov;18(11):2191-8. doi: 10.1038/oby.2010.59. Epub 2010 Mar 25.
8
Long-term successful weight loss improves vascular endothelial function in severely obese individuals.长期成功的体重减轻可改善重度肥胖个体的血管内皮功能。
Obesity (Silver Spring). 2010 Apr;18(4):754-9. doi: 10.1038/oby.2009.482. Epub 2010 Jan 7.
9
The Diabetes Surgery Summit consensus conference: recommendations for the evaluation and use of gastrointestinal surgery to treat type 2 diabetes mellitus.糖尿病手术峰会共识会议：评估和使用胃肠手术治疗 2 型糖尿病的建议。
Ann Surg. 2010 Mar;251(3):399-405. doi: 10.1097/SLA.0b013e3181be34e7.
10
Perioperative safety in the longitudinal assessment of bariatric surgery.肥胖症手术纵向评估中的围手术期安全性
N Engl J Med. 2009 Jul 30;361(5):445-54. doi: 10.1056/NEJMoa0901836.
Zotero 插件